Petosemtamab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Petosemtamab
Treatment and conditionWhere it standsTrials
Petosemtamab for laryngeal diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Petosemtamab for squamous cell carcinoma of head and neckPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3